AcuraStem, Inc. is a privately held, patient-based biotechnology company headquartered in Monrovia, California, developing therapeutics for neurodegenerative diseases including sporadic ALS (amyotrophic lateral sclerosis) and frontotemporal dementia (FTD). The company's proprietary iNeuroRx drug-discovery platform builds disease models from induced pluripotent stem cells (iPSC) taken from individual patients, in place of animal models, and pairs them with machine-learning analysis to identify and validate targets. Its lead antisense oligonucleotide candidate, AS-241 (PIKFYVE), is advancing toward first-in-human testing with California Institute for Regenerative Medicine (CIRM) grant support. AcuraStem is a therapeutics developer rather than a software vendor: it publishes no public API, developer portal, SDK, or machine-readable contract of any kind. This profile records that absence with the probe evidence behind it.
AcuraStem is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Therapeutics, Life Sciences, and Drug Discovery.
AcuraStem’s developer surface includes engineering blog and 10 more developer resources.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
Show this score on your site.
It updates itself when the score changes. Paste this where you link to your API docs:
<a href="https://apis.io/providers/acurastem/"><img src="https://apis.io/badge/acurastem/card.svg" alt="AcuraStem on APIs.io — Kin Score by API Evangelist"></a>
Other styles, a README pill and a shields.io endpoint are on the badge page.
Raise your score.
Agent readiness — checks not met, largest first (exact, from this profile):
Machine-Readable Auth+10 pts — a served openid-configuration/oauth-authorization-server carrying `issuer` (served), else the securitySchemes class in the provider OpenAPIs — bound (mutualTLS, DPoP, Signature) > negotiable (oauth2 authorizationCode/clientCredentials, openIdConnect) > bearer (http bearer, apiKey)
Idempotency+9 pts — OpenAPI mutating operations declare an idempotency key — a header, a request-body property, or a named de-duplication token whose own description says so (verified); else common[].type matches /idempoten/i (documented)
Stable Error Semantics+8 pts — OpenAPI $refs a shared error schema across 4xx/5xx responses (verified), else common[].type includes ErrorCatalog / ErrorCodes / DeclineCodes
13 more unmet checks in the Agent Readiness table above.
Kin Score — facets with the most composite points still available (weight × headroom):
aid: acurastem
name: AcuraStem
description: 'AcuraStem, Inc. is a privately held, patient-based biotechnology company headquartered in Monrovia, California,
developing therapeutics for neurodegenerative diseases including sporadic ALS (amyotrophic lateral sclerosis) and frontotemporal
dementia (FTD). The company''s proprietary iNeuroRx drug-discovery platform builds disease models from induced pluripotent
stem cells (iPSC) taken from individual patients, in place of animal models, and pairs them with machine-learning analysis
to identify and validate targets. Its lead antisense oligonucleotide candidate, AS-241 (PIKFYVE), is advancing toward first-in-human
testing with California Institute for Regenerative Medicine (CIRM) grant support. AcuraStem is a therapeutics developer
rather than a software vendor: it publishes no public API, developer portal, SDK, or machine-readable contract of any kind.
This profile records that absence with the probe evidence behind it.'
url: https://raw.githubusercontent.com/api-evangelist/acurastem/refs/heads/main/apis.yml
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
probe_state: none
source:
- security
generated: '2026-11-06'
method: derived
image: https://acurastem.com/application/files/7516/7235/4056/acs_logo_notag.png
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-09-06'
modified: '2026-10-06'
tags:
- Company
- Biotechnology
- Therapeutics
- Life Sciences
- Drug Discovery
- Neuroscience
- Neurodegenerative Disease
- ALS
- Stem Cells
- Machine Learning
- Private Company
tags_raw:
- Company
- Biotechnology
- Therapeutics
- Life Sciences
- Drug Discovery
- Neuroscience
- Neurodegenerative Disease
- ALS
- Stem Cells
- Machine Learning
- Private Company
- Machine-Learning
apis: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- url: https://acurastem.com/rss/blog
type: BlogRSS
- type: DomainSecurity
url: security/acurastem-domain-security.yml
- type: LLMsTxt
url: llms/acurastem-llms.txt
- type: Website
url: https://acurastem.com/
- type: About
url: https://acurastem.com/about-us
- type: Blog
url: https://acurastem.com/blog
- type: Newsroom
url: https://acurastem.com/media
- type: Careers
url: https://acurastem.com/careers
- type: PrivacyPolicy
url: https://acurastem.com/privacy-policy
- type: LinkedIn
url: https://www.linkedin.com/company/12903559/
- type: X
url: https://x.com/acurastem
x-enrichment:
date: '2026-09-06'
status: minimal
artifacts_added: 3
pass: local-v3
x-coverage:
state: none
reason: not-a-software-company
detail: AcuraStem is a preclinical ALS/FTD therapeutics developer whose entire public web presence is a six-page Concrete
CMS 9.5.2 marketing site (about, science, therapeutics, media, careers) with no developer, API, or data-access section,
no API subdomain resolving in DNS, and an empty GitHub organization with zero public repositories.
evidence:
- url: https://acurastem.com/
status: 200
- url: https://acurastem.com/openapi.json
status: 404
- url: https://acurastem.com/.well-known/api-catalog
status: 404
- url: https://acurastem.com/llms.txt
status: 404
- url: https://acurastem.com/sitemap.xml
status: 200
- url: https://api.github.com/orgs/acurastem
status: 200
checked: '2026-09-06'
Calls without X-API-Key need no key. Calls with it need a paid plan — get a key.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.